Clinical validation of an array CGH test for HER2 status in breast cancer reveals that polysomy 17 is a rare event (Q28245213)

2

0 references

Ryan S Robetorye

3

0 references

Aswani R Bolla

4

0 references

Chris McCaskill

5

0 references

Rashmi K Shah

6

0 references

Mercedes E Gorre

7

0 references

Mansoor S Mohammed

8

0 references

Shelly R Gunn

Polysomy of chromosome 17 in breast cancer tumors showing an overexpression of ERBB2: a study of 175 cases using fluorescence in situ hybridization and immunohistochemistry

9

0 references

language of work or name

English

0 references

publication date

September 2009

0 references

published in

Modern Pathology

0 references

volume

22

0 references

issue

9

0 references

page(s)

1169-75

0 references

cites work

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2009.78

High resolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridization

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2009.78

Application of array-based comparative genomic hybridization to clinical diagnostics

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2009.78

Automated array-based genomic profiling in chronic lymphocytic leukemia: development of a clinical tool and discovery of recurrent genomic alterations

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2009.78

Whole-genome scanning by array comparative genomic hybridization as a clinical tool for risk assessment in chronic lymphocytic leukemia

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2009.78

High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.78

The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy.

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.78

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.78

Amplification of the HER2 gene in breast cancers testing 2+ weak positive by HercepTest immunohistochemistry: false-positive or false-negative immunohistochemistry?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.78

Central HER2 IHC and FISH analysis in a trastuzumab (Herceptin) phase II monotherapy study: assessment of test sensitivity and impact of chromosome 17 polysomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.78

Polysomy 17 in breast cancer: clinicopathologic significance and impact on HER-2 testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.78

Chromosome 17 aneusomy is associated with poor prognostic factors in invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.78

Aneusomy 17 in breast cancer: its role in HER-2/neu protein expression and implication for clinical assessment of HER-2/neu status

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.78

Correction for chromosome-17 is critical for the determination of true Her-2/neu gene amplification status in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.78

Profiling breast cancer by array CGH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.78

Array-CGH and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.78

Characterization of breast cancer by array comparative genomic hybridization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.78

Genomic analysis of the HER2/TOP2A amplicon in breast cancer and breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.78

Preservation of RNA for functional genomic studies: a multidisciplinary tumor bank protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.78

Real-world performance of HER2 testing--National Surgical Adjuvant Breast and Bowel Project experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.78

Validation of a targeted DNA microarray for the clinical evaluation of recurrent abnormalities in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.78

Inconsistency of HER2 test raises questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.78

inferred from DOI database lookup

7 January 2021

based on heuristic

Her-2/neu gene amplification in low to moderately expressing breast cancers: possible role of chromosome 17/Her-2/neu polysomy

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.78

inferred from DOI database lookup

7 January 2021

based on heuristic

Concordance between local and central laboratory HER2 testing in the breast intergroup trial N9831

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.78

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/MODPATHOL.2009.78

1 reference

Consolidated OpenCitations Corpus – April 2017

Dimensions Publication ID

4448625

1030485627

0 references

4448625

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference